|
PD-L1 expression, tumor mutational burden, and microsatellite instability status in 746 pancreas ductal adenocarcinomas. |
|
|
Employment - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine (Inst); Foundation Medicine (Inst); Foundation Medicine (Inst); Foundation Medicine (Inst) |
|
|
Employment - Foundation Medicine; Foundation Medicine |
Leadership - IDOC (I); IDOC (I); Right at Home (I); Right at Home (I) |
Stock and Other Ownership Interests - Foundation Medicine; Foundation Medicine |
|
|
Employment - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
|
|
Employment - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
Stock and Other Ownership Interests - Roche; Roche; Roche; Roche |
Research Funding - Roche; Roche; Roche; Roche |
Patents, Royalties, Other Intellectual Property - Roche; Roche; Roche; Roche |
Travel, Accommodations, Expenses - Roche; Roche; Roche; Roche |
|
|
Employment - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
|
|
Employment - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
Stock and Other Ownership Interests - Roche; Roche; Roche; Roche |
|
|
Employment - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
|
|
Employment - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
|
|
Employment - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
|
|
Employment - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
|
|
Employment - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
Stock and Other Ownership Interests - Roche; Roche; Roche; Roche |
|
|
Employment - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
Leadership - Incysus; Incysus; Incysus; Incysus |
Stock and Other Ownership Interests - Agios; Agios; Agios; Agios; Blueprint Medicines; Blueprint Medicines; Blueprint Medicines; Blueprint Medicines; Exelixis; Exelixis; Exelixis; Exelixis; Genocea Biosciences; Genocea Biosciences; Genocea Biosciences; Genocea Biosciences |
Consulting or Advisory Role - Azitra (I); Azitra (I); Azitra (I); Azitra (I); Princeptx (I); Princeptx (I); Princeptx (I); Princeptx (I); Revolution Medicines; Revolution Medicines; Revolution Medicines; Revolution Medicines |
Patents, Royalties, Other Intellectual Property - patents via FOundation Medicine; patents via FOundation Medicine; patents via FOundation Medicine; patents via FOundation Medicine; Patents via Seres Health on microbiome stuff in non neoplastic disease (I); Patents via Seres Health on microbiome stuff in non neoplastic disease (I); Patents via Seres Health on microbiome stuff in non neoplastic disease (I); Patents via Seres Health on microbiome stuff in non neoplastic disease (I) |
|
|
Employment - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
|
|
Employment - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
Leadership - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Mirati Therapeutics; Mirati Therapeutics; Mirati Therapeutics; Mirati Therapeutics |
Consulting or Advisory Role - Revolution Medicines; Revolution Medicines; Revolution Medicines; Revolution Medicines |
Patents, Royalties, Other Intellectual Property - Receive periodic royalties related to T790M patent awarded to Memorial Sloan Kettering Cancer Center; Receive periodic royalties related to T790M patent awarded to Memorial Sloan Kettering Cancer Center; Receive periodic royalties related to T790M patent awarded to Memorial Sloan Kettering Cancer Center; Receive periodic royalties related to T790M patent awarded to Memorial Sloan Kettering Cancer Center |
|
|
Employment - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
|
|
Employment - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Partners Healthcare; Partners Healthcare; Partners Healthcare; Partners Healthcare |
|
|
Employment - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine |